30Gy IN-RT (Involved-Node Radiotherapy): Clinical Trials

1 trial of 30Gy IN-RT (Involved-Node Radiotherapy), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow 30Gy IN-RT (Involved-Node Radiotherapy): new trials by email Literature Review of 30Gy IN-RT (Involved-Node Radiotherapy) trials Research Report on 30Gy IN-RT (Involved-Node Radiotherapy)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HD17 for Intermediate Stage Hodgkin Lymphoma
BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone), ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine), 30Gy IF-RT (Involved-Field Radiotherapy) - Hodgkin Lymphoma
Phase 3CompletedUniversity of Cologne11002012-01-132020-04-06

Conditions studied

Hodgkin Disease (1)

Sponsors

University of Cologne (1)

Countries

Germany (1)

Top investigators

Andreas Engert, Prof. (1)

Results publications

PMID 30010775, PMID 33539742, PMID 37644732, PMID 40135712, PMID 41074963